InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.25
(
0.20%
)
US TECH 100
18,971.20
(
-0.03%
)
Dow Jones
40,659.76
(
0.24%
)
Brent Oil
79.17
(
0.00%
)
Bitcoin
59,438.01
(
-0.06%
)
Post# of 252903
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: genisi post# 123024

Friday, 07/08/2011 9:32:39 AM

Friday, July 08, 2011 9:32:39 AM

Post# of 252903

Do you know what part of the GT2/3 patients population get a shorter 16 weeks course (depending on having low baseline viral load and perhaps RVR)?




Roche was unable to shorten the treatment duration in their ACCELERATE trial. 16 weeks of treatment with SOC saw lower SVR rates and higher relapse rates. As far as I know 24 weeks of treatment is the standard.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up